Safety follow-up survey for MELAS taurine high-dose therapy subjects

JRCT ID: jRCTs061180015

Registered date:16/01/2019

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: Mitochondrial myopathy,encephalopathy,lactic acidosis, siroke-like episodes(MELAS)
• Date of first enrollment: 03/10/2017
• Target sample size: 5
• Study type: Interventional
• Intervention(s): High-dose taurine supplementation;9-12g/day,three times after meal,every day

Outcome(s)

• Primary Outcome: Safety assessment:adverse event report
• Secondary Outcome: none

Key inclusion & exclusion criteria

• Age minimum: none
• Age maximum: none
• Gender: Both

Include criteria

1.Subjects continuing the taurine bulk mass method in doctor-initiated clinical trials beginning 1n 2013
2.Written informed consent before beginning treatment

• Exclude criteria: none

Related Information

• Primary Sponsor: Sunada Yoshihide
• Secondary ID(s): UMIN000029376